(株)リボミックの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4591/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/11/10 | 日証協 | 234,900株 | +33.47% | 107,312株 | +343.33% | 326,908株 | +6.66% | 44,100株 | +170.55% |
| 2017/11/02 | 日証協 | 176,000株 | +1.79% | 24,206株 | +1.28% | 306,508株 | +2.65% | 16,300株 | -32.64% |
| 2017/10/27 | 日証協 | 172,900株 | -28.88% | 23,900株 | +443.18% | 298,608株 | -12.2% | 24,200株 | -18.24% |
| 2017/10/20 | 日証協 | 243,100株 | +0.62% | 4,400株 | -18.52% | 340,108株 | +0.38% | 29,600株 | +305.48% |
| 2017/10/13 | 日証協 | 241,600株 | +1.17% | 5,400株 | -59.4% | 338,808株 | +1.62% | 7,300株 | -62.18% |
| 2017/10/06 | 日証協 | 238,800株 | +4.42% | 13,300株 | +411.54% | 333,408株 | +6.8% | 19,300株 | +67.83% |
| 2017/09/29 | 日証協 | 228,700株 | -3.22% | 2,600株 | +1200% | 312,176株 | -2.57% | 11,500株 | +134.69% |
| 2017/09/22 | 日証協 | 236,300株 | -4.18% | 200株 | -99.73% | 320,408株 | -3.78% | 4,900株 | +81.48% |
| 2017/09/15 | 日証協 | 246,600株 | -7.05% | 74,400株 | +86% | 333,008株 | -1.57% | 2,700株 | -71.88% |
| 2017/09/08 | 日証協 | 265,300株 | -1.45% | 40,000株 | +17.99% | 338,308株 | +0.27% | 9,600株 | +269.23% |
| 2017/09/01 | 日証協 | 269,200株 | -2.92% | 33,900株 | -52.52% | 337,408株 | -0.88% | 2,600株 | -57.38% |
| 2017/08/25 | 日証協 | 277,300株 | +12.27% | 71,400株 | +475.81% | 340,408株 | +0.44% | 6,100株 | -1.61% |
| 2017/08/18 | 日証協 | 247,000株 | +3.61% | 12,400株 | +69.86% | 338,908株 | +2.05% | 6,200株 | +16.98% |
| 2017/08/10 | 日証協 | 238,400株 | +1.1% | 7,300株 | -61.98% | 332,108株 | +0.76% | 5,300株 | -36.98% |
| 2017/08/04 | 日証協 | 235,800株 | +1.59% | 19,200株 | +93.94% | 329,608株 | +0.61% | 8,410株 | +546.92% |
| 2017/07/28 | 日証協 | 232,100株 | 0% | 9,900株 | +83.33% | 327,598株 | +0.96% | 1,300株 | -77.19% |
| 2017/07/21 | 日証協 | 232,100株 | +2.29% | 5,400株 | +170% | 324,498株 | +0.68% | 5,700株 | +66.42% |
| 2017/07/14 | 日証協 | 226,900株 | +1.43% | 2,000株 | -69.7% | 322,298株 | +1.33% | 3,425株 | -31.64% |
| 2017/07/07 | 日証協 | 223,700株 | +1.73% | 6,600株 | -13.16% | 318,073株 | +0.35% | 5,010株 | +78.93% |
※株式分割は考慮していませんのでご注意ください。
Page Top